Enzyme PapB could boost longevity and potency of Ozempic-like weight‑loss drugs
TL;DR Summary
Scientists at the University of Utah found that the enzyme PapB can macrocyclize GLP-1–like drug peptides, increasing their stability and duration in the body, potentially making Ozempic/Wegovy‑type weight‑loss drugs more potent and longer‑lasting.
- Scientists discover enzyme that could supercharge Ozempic-like weight-loss drugs New York Post
- Utah scientists find PapB could extend Ozempic and Wegovy effects NewsBytes
- Scientists discover enzyme that could supercharge Ozempic ScienceDaily
- Could a New Enzyme Make Weight Loss Drugs Last Longer and Become More Affordable? vocal.media
- This enzyme can make diabetes, weight-loss drugs more effective NewsBytes
Reading Insights
Total Reads
0
Unique Readers
6
Time Saved
22 min
vs 22 min read
Condensed
99%
4,373 → 33 words
Want the full story? Read the original article
Read on New York Post